Põltsamaa Uus Apteek OÜ

Year	Period	Submitted	Status
2025	01.01.2025 – 31.12.2025	09.04.2026	Valid	PDF
2024	01.01.2024 – 31.12.2024	22.06.2025	Valid	PDF
2023	01.01.2023 – 31.12.2023	10.05.2024	Valid	PDF
2022	01.01.2022 – 31.12.2022	30.06.2023	Valid	PDF
2021	01.01.2021 – 31.12.2021	21.06.2022	Valid	PDF
2020	01.01.2020 – 31.12.2020	28.06.2021	Valid	PDF
2019	01.01.2019 – 31.12.2019	04.06.2020	Valid	PDF
2018	01.01.2018 – 31.12.2018	28.06.2019	Valid	PDF
2017	01.01.2017 – 31.12.2017	17.07.2018	Valid	PDF
2016	01.01.2016 – 31.12.2016	30.06.2017	Valid	PDF
2015	01.01.2015 – 31.12.2015	20.06.2016	Valid	PDF
2014	01.01.2014 – 31.12.2014	17.06.2015	Valid	PDF
2013	01.01.2013 – 31.12.2013	08.05.2014	Valid	PDF
2012	01.01.2012 – 31.12.2012	27.06.2013	Valid	PDF
2011	01.01.2011 – 31.12.2011	28.06.2012	Valid	PDF
2010	01.01.2010 – 31.12.2010	17.06.2011	Valid	PDF
2009	01.01.2009 – 31.12.2009	29.06.2010	Valid	PDF
2008	01.01.2008 – 31.12.2008	29.06.2009	Valid	PDF
2007	01.01.2007 – 31.12.2007	01.07.2008	Valid	PDF
2006	01.01.2006 – 31.12.2006	02.07.2007	Valid	PDF
2005	01.01.2005 – 31.12.2005	29.06.2006	Valid	PDF
2004	01.01.2004 – 31.12.2004	29.06.2005	Valid	PDF
2003	01.01.2003 – 31.12.2003	30.06.2004	Valid	PDF
2002	01.01.2002 – 31.12.2002	01.07.2003	Valid	PDF
2001	01.01.2001 – 31.12.2001	01.07.2002	Valid	PDF
2000	01.01.2000 – 31.12.2000	02.07.2001	Valid	PDF

Unsubmitted declarations

No unsubmitted declarations found

No unsubmitted declarations as of 20.10.2026.

Check company creditworthiness in seconds

Detailed reviews of company financial risks and strengths

3€ /monthGet started

Tax debt Reports Declarations Court decisions–Official announcements1 TTJA decisions–Real estate–.ee domains–Licenses–Regulations12 Public transactions1515 Grants–State aid–Public procurement–Holdings in companies–Enforcement proceedings Payment orders

Tax data

Period	State taxes	Labour taxes	Taxable turnover	Employees
2026 Q3	32 437 €	25 742 €	508 472 €+9,6%	7
2026 Q2	29 009 €	22 273 €	464 097 €−2,3%	8
2026 Q1	36 538 €	23 630 €	474 826 €−4,6%	8
Total 2026:	97 984 €	71 645 €	1,45 M €
2025 Q4	30 794 €	24 365 €	497 462 €−1,9%	8
2025 Q3	33 359 €	25 991 €	506 952 €+3,9%	8
2025 Q2	31 259 €	23 587 €	487 918 €+0,8%	8
2025 Q1	34 876 €	22 276 €	484 152 €−4,5%	8
Total 2025:	130 288 €	96 219 €	1,98 M €
2024 Q4	32 652 €	20 642 €	506 930 €+1,3%	7
2024 Q3	31 916 €	22 261 €	500 667 €+0,8%	8
2024 Q2	31 488 €	21 399 €	496 698 €−2,6%	6
2024 Q1	29 202 €	20 060 €	509 954 €+4,2%	6
Total 2024:	125 258 €	84 362 €	2,01 M €
2023 Q4	31 044 €	20 419 €	489 570 €+1,8%	6
2023 Q3	30 261 €	21 775 €	480 859 €+0,6%	6
2023 Q2	30 260 €	20 040 €	477 811 €−0,9%	6
2023 Q1	29 351 €	19 750 €	482 291 €−1,3%	6
Total 2023:	120 916 €	81 984 €	1,93 M €
2022 Q4	29 991 €	20 785 €	488 587 €+7,5%	6
2022 Q3	28 993 €	20 147 €	454 538 €+2,1%	7
2022 Q2	30 924 €	20 189 €	445 229 €−0,9%	7
2022 Q1	30 316 €	19 614 €	449 272 €−11,2%	7
Total 2022:	120 224 €	80 735 €	1,84 M €
2021 Q4	39 473,29 €	24 018,98 €	505 712,09 €+7,1%	7
2021 Q3	37 314,02 €	24 881,14 €	472 389,80 €+2,4%	9
2021 Q2	38 086,13 €	24 372,46 €	461 127,36 €+3,7%	9
2021 Q1	40 229,07 €	23 196,49 €	444 495,01 €−4,2%	10
Total 2021:	155 102,51 €	96 469,07 €	1,88 M €
2020 Q4	33 207,58 €	22 216,07 €	463 997,30 €+5,3%	10
2020 Q3	37 250,21 €	22 641,84 €	440 808,17 €−5,7%	10
2020 Q2	35 956,17 €	20 202,87 €	467 240,63 €+3,6%	10
2020 Q1	38 030 €	23 678 €	450 955 €−0,4%	9
Total 2020:	144 443,96 €	88 738,78 €	1,82 M €
2019 Q4	36 954 €	20 096 €	452 716 €+10,9%	10
2019 Q3	30 622 €	20 732 €	408 326 €−7,7%	9
2019 Q2	30 871 €	19 578 €	442 366 €+2,6%	9
2019 Q1	21 607 €	18 351 €	430 967 €+15,0%	8
Total 2019:	120 054 €	78 757 €	1,73 M €
2018 Q4	27 957 €	17 502 €	374 782 €+13,0%	7
2018 Q3	24 079 €	17 807 €	331 712 €−2,4%	7
2018 Q2	26 632 €	16 121 €	339 869 €+12,4%	7
2018 Q1	24 597 €	16 721 €	302 314 €+3,5%	6
Total 2018:	103 265 €	68 151 €	1,35 M €
2017 Q4	13 863 €	13 599 €	292 169 €−3,5%	6
2017 Q3	20 756 €	18 485 €	302 647 €−0,7%	6
2017 Q2	21 068 €	14 861 €	304 795 €−1,8%	6
2017 Q1	25 507 €	18 018 €	310 434 €+22,9%	6
Total 2017:	81 194 €	64 963 €	1,21 M €
2016 Q4	23 181 €	13 340 €	252 595 €−20,8%	6
2016 Q3	24 172 €	16 835 €	318 774 €+6,6%	6
2016 Q2	27 179 €	15 797 €	299 124 €−13,9%	6
2016 Q1	26 986 €	18 353 €	347 516 €+10,1%	6
Total 2016:	101 518 €	64 325 €	1,22 M €
2015 Q4	20 383 €	12 551 €	315 649 €+2,0%	6
2015 Q3	22 272 €	12 306 €	309 487 €+21,7%	6
2015 Q2	18 905 €	10 113 €	254 339 €−22,1%	6
2015 Q1	22 886 €	12 976 €	326 352 €	6
Total 2015:	84 446 €	47 946 €	1,21 M €

Revenue by industry

	2023	2024	2025
Retail sale of medicines		2 010 960 €	1 978 186 €
Pharmacy activities	1 919 758 €

Tax debts

No tax debt found

No tax debt as of 20.10.2026

Representatives

	Personal ID code
Ülle Rebane	46307XXXXXX	04.07.1963 (63)	board member (manager)	29.05.1996	-

3 inactive records hidden, extended access to the information portal is required to view history!

3€ /monthGet started

Shareholders

	Personal ID code
Ülle Rebane	46307XXXXXX	04.07.1963 (63)	Shareholder	2 556 EUR	100,00%	Sole ownership	19.03.2026	-

3 inactive records hidden, extended access to the information portal is required to view history!

3€ /monthGet started

Ultimate beneficial owners

	Personal ID code
Ülle Rebane	46307XXXXXX	04.07.1963 (63)	Direct holding	27.09.2018	-

3 inactive records hidden, extended access to the information portal is required to view history!

3€ /monthGet started

Holdings in companies

No holdings in companies found

Company has no holdings in other companies

2026 Q3

Turnover

Amount: 508 472 €
Monthly average: 169 491 €
Per employee: 24 213 €
Equity ratio: 6 631,09%

Labour taxes

Turnover ratio: 5,06%
Tax ratio: 79,36%
Monthly average: 8 581 €
Per employee: 1 144 €

State taxes

Monthly average: 10 812 €
Turnover ratio: 6,38%

Estimated salary

Gross salary: 2 144 €
Net salary: 1 766 €

Aggregate data

Last 5 yrsAll

	2025	2024	2023	2022	2021	2020	2019
Current assets	335 404 €+7,4%	312 188 €−8,6%	341 492 €−2,4%	350 062 €+4,3%	335 511 €−3,1%	346 365 €+12,4%	308 258 €
Non-current assets	1 357 €+147%	550 €−35,9%	858 €−76,1%	3 591 €−74,4%	14 049 €−95,1%	287 042 €−8,4%	313 334 €
Total assets	336 761 €+7,7%	312 738 €−8,6%	342 350 €−3,2%	353 653 €+1,2%	349 560 €−44,8%	633 407 €+1,9%	621 592 €
Short-term liabilities	322 959 €+60,3%	201 487 €−10,5%	225 104 €	225 073 €−1,7%	229 041 €+22,8%	186 573 €+12,2%	166 313 €
Long-term liabilities	-	-	-	-	1 259 €−79,8%	6 237 €−43,9%	11 120 €
Total liabilities	322 959 €+60,3%	201 487 €−10,5%	225 104 €	225 073 €−2,3%	230 300 €+19,4%	192 810 €+8,7%	177 433 €
Share or stock capital	-	-	-	-	-	-	-
Retained earnings	8 439 €−84,5%	54 434 €+18,9%	45 768 €+25,6%	36 448 €+88,0%	19 392 €−94,6%	360 278 €+2,2%	352 514 €
Net profit	2 551 €−95,3%	54 005 €−21,4%	68 666 €−23,1%	89 320 €−8,0%	97 056 €+25,2%	77 507 €−12,7%	88 833 €
Equity	13 802 €−87,6%	111 251 €−5,1%	117 246 €−8,8%	128 580 €+7,8%	119 260 €−72,9%	440 597 €−0,8%	444 159 €
Turnover	1 978 186 €−1,6%	2 010 960 €+4,8%	1 919 758 €+3,6%	1 853 146 €−0,8%	1 867 707 €+3,0%	1 813 557 €+5,1%	1 726 064 €
Profit margin	0,1%	2,7%	3,6%	4,8%	5,2%	4,3%	5,1%

Financial ratios

	2022	2021
Profit and cash flow
EBITDA	109 897 €	142 376 €
Liquidity
Current ratio	1,6	1,5
Quick ratio	0,7	0,7
Cash ratio	0,3	0,4
Efficiency
Days sales outstanding (dso)	15,8	12,7
Asset turnover	5,3	3,8
Structure
Debt ratio	0,6	0,7
Profitability
Operating margin	5,4%	6,3%
Net profit margin	4,8%	5,2%
Return on assets (roa)	25,4%	19,7%
Return on equity (roe)	69,5%	81,4%

Data export

These figures for over 281,000 companies, in one table

Revenue, EBITDA, ROE, ROA and other ratios
Up to five years of reports at once
Excel, CSV or JSON, updated daily

See how it works

To view all financial ratios, you need to subscribe to extended access to the info portal!

3€ /monthGet started

Licences & notices

No licenses and notices found

Company has no active licenses and business activity notices

Regulations


Ä 20000676 / 11	20.03.2026	Entry – Amendment entry	-	Entered into force20.03.2026
Ä 20000676 / 10	01.09.2023	Entry – Amendment entry	-	Entered into force01.09.2023
Ä 20000676 / 9	27.10.2021	Entry – Division entry of transferring entity (second, constitutive entry)	-	Entered into force27.10.2021
Ä 20000676 / 8	17.01.2018	Entry – Amendment entry	-	Entered into force17.01.2018
Ä 20000676 / 7	22.12.2017	Entry – Amendment entry	-	Entered into force22.12.2017

Real estate

No real estate found

Company has no real estate

Consumer Disputes Committee decisions

No consumer dispute committee decisions found

Company has not been issued consumer dispute committee decisions

Court decisions

No court decisions found

The company has no court decisions

Official announcements


Notice of division of a company	28.10.2021	PDF

Public transactions


29.09.2026	Tervisekassa	5 573,98 €Received	SOCIAL BENEFITSOther health care, incl. administration
29.09.2026	Tervisekassa	2 422,70 €Received	SOCIAL BENEFITSOther health care, incl. administration
29.09.2026	Tervisekassa	192,11 €Received	SOCIAL BENEFITSOther health care, incl. administration
29.09.2026	Tervisekassa	138,85 €Received	SOCIAL BENEFITSOther health care, incl. administration
25.09.2026	Tervisekassa	7 878,44 €Received	SOCIAL BENEFITSOther health care, incl. administration

Funded projects

No funded projects found

The company has no projects funded by EU or foreign grants

State aid

No state aid found

The company has not been granted state aid or de minimis aid

Public procurement contracts

No public procurement contracts found

The company has no public procurement contracts

.ee domains

No domains found

Company has no valid .ee domains

Enforcement proceedings

No enforcement proceedings found

Company has no active debts with bailiffs

Payment orders

No payment orders found

Company has no court-ordered payment orders

Data comes from public registers.